PRESS RELEASE published on 03/12/2024 at 07:00, 1 year 9 months ago FUCHS concludes financial year 2023 with new record highs FUCHS concludes financial year 2023 with new record highs, achieving sales revenues of EUR 3,541 million and EBIT of EUR 413 million. Forecast for 2024 projects sales revenues around EUR 3.6 billion and EBIT around EUR 430 million EBIT Financial Year 2023 FUCHS SE Record Highs Sales Revenues
REGULATED PRESS RELEASE published on 03/12/2024 at 07:00, 1 year 9 months ago Biophytis annonce sa participation à plusieurs événements en Europe et aux Etats-Unis au cours des prochains mois Biophytis annonce sa participation à plusieurs événements en Europe et aux Etats-Unis au cours des prochains mois, dont des conférences scientifiques et des congrès de business development pour établir des partenariats. Découvrez les détails Biophytis Europe Participation États-Unis Événements
REGULATED PRESS RELEASE published on 03/12/2024 at 07:00, 1 year 9 months ago Biophytis announces its participation in several events in Europe and the United States over the coming months Biophytis to participate in key events in Europe and the USA, showcasing latest advancements in biotechnology and seeking partnerships for future growth Biophytis Biotechnology Partnerships Participation Events
PRESS RELEASE published on 03/12/2024 at 06:55, 1 year 9 months ago Operationally successful FY 2023 for TAG; sales results in Poland exceed guidance; significantly increased net liquidity from disposals in Germany; LTV stable despite portfolio devaluation TAG Immobilien AG reports successful FY 2023 with sales in Poland surpassing guidance and increased net liquidity from German disposals. LTV remains stable despite portfolio devaluation FY 2023 TAG Immobilien AG Sales Results Net Liquidity Portfolio Devaluation
PRESS RELEASE published on 03/12/2024 at 06:45, 1 year 9 months ago Galenica poursuit sa croissance au cours de l’exercice 2023 Le Groupe Galenica a enregistré une forte croissance du chiffre d'affaires de 4.4% au cours de l'exercice 2023 et prévoit une hausse de 8% à 11% pour l'EBIT ajusté en 2024. Détails dans le Rapport annuel 2023 Chiffre D'affaires Croissance EBIT Ajusté Rapport Annuel 2023 Galenica
PRESS RELEASE published on 03/12/2024 at 06:45, 1 year 9 months ago Galenica continues to grow in the 2023 financial year Galenica Group achieves 4.4% sales growth in 2023, proposing stable dividend. Expects 3-5% sales growth in 2024, increased adjusted EBIT by 8-11% 2024 Outlook Sales Growth Dividend Proposal Galenica Group Adjusted EBIT Increase
PRESS RELEASE published on 03/12/2024 at 06:45, 1 year 9 months ago PolyPeptide with record revenue growth of 43% in H2 2023 versus H1 2023; operational improvements yielding increased profitability and cash flow PolyPeptide announces record revenue growth of 43% in H2 2023 compared to H1 2023, along with enhanced profitability and cash flow. Details on 2023 results and 2024 guidance provided Revenue Growth Cash Flow Profitability 2023 Results PolyPeptide
PRESS RELEASE published on 03/12/2024 at 06:30, 1 year 9 months ago Medartis increases sales by 21% (CER) and improves its underlying EBITDA margin to 16%
PRESS RELEASE published on 03/12/2024 at 06:30, 1 year 9 months ago Affluent Medical annonce le succès de la première implantation chez l’homme de son sphincter artificiel Artus pour le traitement de l’incontinence urinaire d’effort. Affluent Medical annonce le succès de la première implantation chez l'homme de son sphincter artificiel Artus pour le traitement de l'incontinence urinaire d'effort Affluent Medical Dispositif Médical Incontinence Urinaire Artus Implantation
PRESS RELEASE published on 03/12/2024 at 06:30, 1 year 9 months ago Affluent Medical announces successful first-in-human implantation of its artificial sphincter Artus for the treatment of stress urinary incontinence. Affluent Medical announces successful first-in-human implantation of its artificial sphincter Artus for the treatment of stress urinary incontinence in Prague, Czech Republic. The innovative medical device offers hope for the estimated 400 million patients affected worldwide Medical Device Affluent Medical Urinary Incontinence Artus First-in-human Implantation
Published on 12/23/2025 at 23:35, 31 minutes ago Bausch Health Announces Final Results and Expiration of Exchange Offers
Published on 12/23/2025 at 23:15, 51 minutes ago Relevant Gold Recaps Successful 2025 Exploration Season and Positions for Data-Driven 2026 in Wyoming
Published on 12/23/2025 at 23:00, 1 hour 6 minutes ago NXT Energy Solutions Acquires Complete Ownership of SFD Technology Including All Remaining SFD Application Rights
Published on 12/23/2025 at 22:35, 1 hour 31 minutes ago Alset AI Announces Closing of Non-Brokered Private Placement Offering With Strategic Investors
Published on 12/23/2025 at 21:10, 2 hours 56 minutes ago AmeriTrust Announces Closing First Tranche of Brokered Offering for $36,187,200
Published on 12/23/2025 at 22:15, 1 hour 51 minutes ago Games of the Future 2025 Concludes After Six Action-Packed Days
Published on 12/23/2025 at 19:21, 4 hours 45 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 12/23/2025 at 17:45, 6 hours 21 minutes ago Ordissimo SA: ORDISSIMO FINALISE L’acquisition de R-COST Et lance opérationnellement son nouveau pôle de services IT
Published on 12/23/2025 at 12:48, 11 hours 18 minutes ago Evolution des droits de vote au 23 décembre 2025
Published on 12/23/2025 at 12:39, 11 hours 27 minutes ago CDA - Acquisition of Sport4lux in Luxembourg
Published on 12/23/2025 at 12:35, 11 hours 31 minutes ago CDA - Acquisition de Sport4lux au Luxembourg
Published on 12/22/2025 at 18:33, 1 day 5 hours ago ABEO SE RENFORCE ET OBTIENT UNE TRÈS LARGE MAJORITÉ DU CAPITAL DE VOGO AVEC 90,84% DÉTENUS À L’ISSUE DE L’OFFRE RÉOUVERTE
Published on 12/22/2025 at 18:05, 1 day 6 hours ago Covivio - Treasury shares transactions between December 15th , 2025 and December 19th, 2025